CHWY Chewy absorbed dual downgrades today despite beating Q4 estimates. BNP Paribas and Citizens trimmed forecasts on the $6.5B pet retailer. The stock slid as analysts flagged margin pressure.
INTC Intel grabbed a price target boost from KeyBanc. The firm maintained overweight and raised its target to $70. The $253B chipmaker held momentum as semiconductor optimism persisted.
PRZO ParaZero Technologies secured fresh defense orders from Israeli entities. The counter-drone specialist grabbed attention as Middle East conflict entered week four. Contract value stayed undisclosed.
VAL Valaris landed a 1,064-day Petrobras extension adding $447M to backlog. Rate adjustments cut $21M from the deal. The offshore driller navigated energy market volatility as oil held above $95.
STXS Stereotaxis received FDA 510(k) clearance for its Synchrony System. The medtech approval came as regulatory catalysts dominated small-cap trading.
Retail and defense names drew divergent analyst treatment reflecting sector-specific pressures.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
